Literature DB >> 17308953

Unmet needs in fracture prevention: new European guidelines for the investigation and registration of therapeutic agents.

E Seeman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308953     DOI: 10.1007/s00198-007-0350-z

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  52 in total

1.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

2.  Sick individuals and sick populations.

Authors:  G Rose
Journal:  Int J Epidemiol       Date:  2001-06       Impact factor: 7.196

3.  The burden of osteoporotic fractures: a method for setting intervention thresholds.

Authors:  J A Kanis; A Oden; O Johnell; B Jonsson; C de Laet; A Dawson
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

Review 4.  Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women.

Authors:  P Garnero; P D Delmas
Journal:  J Musculoskelet Neuronal Interact       Date:  2004-03       Impact factor: 2.041

Review 5.  Comparison of treatment effects between animal experiments and clinical trials: systematic review.

Authors:  Pablo Perel; Ian Roberts; Emily Sena; Philipa Wheble; Catherine Briscoe; Peter Sandercock; Malcolm Macleod; Luciano E Mignini; Pradeep Jayaram; Khalid S Khan
Journal:  BMJ       Date:  2006-12-15

6.  Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

Authors:  T Mashiba; T Hirano; C H Turner; M R Forwood; C C Johnston; D B Burr
Journal:  J Bone Miner Res       Date:  2000-04       Impact factor: 6.741

7.  Osteoporosis disease management in a rural health care population: hip fracture reduction and reduced costs in postmenopausal women after 5 years.

Authors:  E D Newman; W T Ayoub; R H Starkey; J M Diehl; G C Wood
Journal:  Osteoporos Int       Date:  2003-02-18       Impact factor: 4.507

8.  The components of excess mortality after hip fracture.

Authors:  J A Kanis; A Oden; O Johnell; C De Laet; B Jonsson; A K Oglesby
Journal:  Bone       Date:  2003-05       Impact factor: 4.398

9.  Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial.

Authors:  John A Kanis; Olof Johnell; Dennis M Black; Robert W Downs; Somnath Sarkar; Thomas Fuerst; Roberta J Secrest; Imre Pavo
Journal:  Bone       Date:  2003-09       Impact factor: 4.398

10.  Bone mineral density thresholds for pharmacological intervention to prevent fractures.

Authors:  Ethel S Siris; Ya-Ting Chen; Thomas A Abbott; Elizabeth Barrett-Connor; Paul D Miller; Lois E Wehren; Marc L Berger
Journal:  Arch Intern Med       Date:  2004-05-24
View more
  2 in total

1.  Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US.

Authors:  C Pike; H G Birnbaum; M Schiller; E Swallow; R T Burge; E T Edgell
Journal:  Osteoporos Int       Date:  2010-05-20       Impact factor: 4.507

Review 2.  Bone physiology, disease and treatment: towards disease system analysis in osteoporosis.

Authors:  Teun M Post; Serge C L M Cremers; Thomas Kerbusch; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2010       Impact factor: 6.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.